Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

NNC0519-0130

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Novo Nordisk · Phase 1 · Completed · Enrollment 161

NCT05363774

EudraCT 2021-004856-41

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Single ascending dose (SAD) partn/rn/rn/rn/r
Multiple ascending dose (MAD) QD partn/rn/rn/rn/r
Type 2 diabetes (T2D) partn/rn/rn/rn/r
MAD QW partn/rn/rn/rn/r

Not shown

  • Single ascending dose (SAD) part: endpoint not reported
  • Multiple ascending dose (MAD) QD part: endpoint not reported
  • Type 2 diabetes (T2D) part: endpoint not reported
  • MAD QW part: endpoint not reported